![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 50, 35359-35366, December 10, 1999
-Cyclodextrins Greatly Enhance Translocation of Hydrophobic
Fluorescent Phospholipids from Vesicles to Cells in Culture
From the Institute of Biomedicine, Department of Medical Chemistry, University of Helsinki, Siltavuorenpenger 10 A, 00014 Helsinki, Finland
| |
ABSTRACT |
|---|
|
|
|---|
Short-chain, fluorescent derivatives are commonly
used to investigate intracellular phospholipid trafficking. However,
their use can yield misleading results because they, unlike the native species, can rapidly distribute between organelles due to their low
hydrophobicity. On the other hand, hydrophobic derivatives are very
difficult to introduce to cells and thus have hardly been used. Here we
show that carboxyethylated In eukaryotic cells, most phospholipids are synthesized in the
endoplasmic reticulum but are abundant in all organelle membranes (1).
Accordingly, efficient transport of those phospholipids from the
endoplasmic reticulum to the other organelles must take place. There
are several mechanisms that could accomplish this transfer,
i.e. vesicle traffic, spontaneous or protein-assisted diffusion via the cytoplasm, or diffusion via membrane fusion (or
hemifusion) sites (reviewed in Refs. 2 and 3). However, the involvement
and relative contributions of these various transport mechanisms have
not been established. It is also unknown how intracellular trafficking
of phospholipids is controlled so that the different membranes can
maintain their distinct lipid compositions. A major reason for the lack
of this crucial information is largely a technical one: there are no
simple and efficient methods to trace movements and distributions of
phospholipids inside the cell. For instance, immunolocalization, which
has played the key role in resolving the transport mechanism and
sorting of proteins, cannot be applied, as (i) phospholipids are
generally poor antigens, (ii) most phospholipids are abundant in all
membranes and thus there is no adequate concentration gradient, and
(iii) it is not possible to obtain stoichiometric complex formation due
to the large size of the antibody molecule.
To circumvent the tracing problem, short-chain fluorescent
(NBD6) lipids were introduced to this field by Pagano and
co-workers (reviewed in Refs. 4 and 5). Although such derivatives have proven to be very useful to study sphingolipid trafficking (6, 7), they
have been less successful when glycerophospholipid transport is being
investigated. One reason for this is that short chain
NBD6-phospholipids are rapidly degraded (half-life is 1 h
or less) in mammalian cells at the physiological temperature (8-10).
The altered conformation of such lipids (11, 12) may render them
targets for some cellular phospholipases. However, an even more serious
limitation is that the short chain lipids, unlike the natural ones, can
distribute spontaneously between all accessible membrane surfaces due
to their hydrophilicity (8). Thus, their use is very problematic when
one studies intracellular trafficking of lipids having access to the
cytoplasmic leaflet of organelle membranes, which is the case with most
glycerophospholipids. Accordingly, fluorescent derivatives with
hydrophobicity similar to that of endogenous phospholipids need to be
employed to obtain relevant information on intracellular trafficking of
the latter. Unfortunately, such derivatives are difficult to introduce
into cells just because of their hydrophobicity. Although several
methods allowing introduction of hydrophobic fluorescent lipids to
cells have been reported (13), none of them has gained significant popularity, for various reasons.
Recently, Lipids and Other Reagents--
All unlabeled lipids were
obtained from Avanti Polar Lipids (Alabaster, AL).
Bodipy12-PC,1
-PE, and -SM, as well as NBD12PC, were supplied by
Molecular Probes Europe (Leiden, Netherlands). Bodipy-PC and -PE were
repurified shortly before use by HPLC on silica gel and Bodipy-SM on a
reverse phase column. Typically, such repurification greatly reduced
labeling of cells in the absence of cyclodextrin by removing free fatty acid and/or other impurities. The pyrenylacyl glycerophospholipids were
synthesized as described previously (21, 22). Pyrenyldecanoyl sphingomyelin was synthesized using the method of Via et al.
(23) and purified by HPLC on a silica column using a
chloroform/methanol gradient and then further purified on an
octadecylsilica column. [3H]Cholesterol oleate was
synthesized as described previously (24). All labeled lipids were at
least 99.5% pure as determined by HPLC. The cyclodextrins were
obtained from Cyclolab (Budapest, Hungary). The cell culture media were
obtained from Life Technologies, Inc., and all other chemicals were
from Sigma.
Assays for Cyclodextrin-mediated Lipid Transfer and
Binding--
The previously described assays (16) were employed to
study the transfer and binding of pyrenyl lipids. The donor vesicles consisted of a pyrenyl lipid, POPC, and TNP-PE (0.2:45:5 nmol), whereas
the acceptor vesicles consisted of POPC and POPA (480:20 nmol).
Transfer of the pyrenyl lipid molecules from quenched donor vesicles to
acceptor vesicles results in de-quenching of pyrene fluorescence, which
is recorded. The initial slope of the progress curve is used as the
measure of transfer rate. To measure binding, donor vesicles were
titrated with a cyclodextrin solution, and the pyrene fluorescence
intensity was recorded. Fluorescence measurements were carried out
using either a Hitachi F-4000 or PTI QuantaMaster spectrofluorometer
equipped with a thermostatted cuvette holder. The excitation and
emission wavelengths were 345 and 395 nm for pyrene and 480 and 520 nm
for Bodipy, respectively. All measurements were carried out at
25 °C.
Cell Culture--
Normal Human fibroblasts (GM08333) and BHK-21
cells were grown as before (18, 25). For microscopy, the cells were
plated on round 32-mm coverslips placed in home-built aluminum-Teflon chambers. Before use, the coverslips had been cleaned by treating them
for 1 h at 50 °C with 1 M NaOH and 1 M
HCl each, followed by washing with water and ethanol. After 1-2 h of
incubation at 37 °C, the inoculum was removed, and the attached
cells were washed, covered with normal growth medium, and placed in the
incubator. Labeling and imaging were carried out the following day.
This cultivation protocol considerably reduced the amount of cell
debris on the coverslips.
Incubation of cells with cyclodextrins and donor
vesicles--
Cell monolayers were washed twice with
CO2-independent minimal medium (I-MEM), twice with
phosphate-buffered saline and then incubated at room temperature or
37 °C in I-MEM containing the donor vesicles with or without
cyclodextrin. The donor vesicle compositions are specified under
"Results." The CE- Fluorescence Imaging--
After washing, the cells on coverslips
were covered with I-MEM containing glucose, glucose-oxidase, and
catalase to deplete oxygen from the medium (28). Oxygen depletion
virtually eliminates photobleaching of the pyrene chromophore but has
no detectable effect on fluorophore distribution or cell morphology
(25). Imaging was carried out on a Zeiss Axiovert 10 microscope
equipped with a cooled CCD camera as detailed (25). For pyrene lipids, a 340 nm (BP, 11 nm) excitation filter, a 480 nm (BP, 80 nm) emission filter, and a 375 nm dichroic mirror were used. The images were corrected for background fluorescence and scatter by subtracting a
background image obtained with a 360 nm (BP, 5 nm) excitation filter
and multiplied with an empirically determined factor. As will be shown
elsewhere,2 pyrene is not
significantly excited with the 360 nm filter, whereas the background
fluorescence/scatter is excited similarly with the 360 and 340 nm
filters. A particularly useful feature of this type of background
correction is that it properly accounts for the typically uneven
distribution of cellular autofluorescence. With the Bodipy lipids 480 nm (BP, 30 nm) and 535 nm (BP, 40 nm) excitation and emission filters
were used, respectively.
Other Methods--
Lactate dehydrogenase was determined
essentially as described (29). Concentrations of unlabeled
phospholipids were determined by a phosphate assay (30) and protein
concentrations by a fluorescamine assay (31).
CE- CE-
To study the mechanism of CE- Effect of the Lipid Head Group and Backbone Structure on the Rate
of CE- CE-
For imaging studies, we employed dipyrenyl phospholipids,
i.e. species containing two pyrene-labeled chains, because
such species display strong excimer fluorescence (peak at 480 nm) due to frequent interpyrene collisions (32). This excimer fluorescence is
more readily visualized with our imaging system than the monomer fluorescence (peaks at 378 and 395 nm) that the monopyrenyl lipids mainly emit. Furthermore, the wide separation of the excitation (345 nm) and emission peaks avoids excitation/emission crossover, as well as
allowing efficient correction for background fluorescence as described
under "Experimental Procedures." Yet another important advantage of
the dipyrenyl derivatives is that the (possible) presence of fatty acid
and/or lysolipid impurities in the donor vesicles does not interfere
with interpretation of the images, because these compounds do not
display detectable excimer fluorescence under the conditions used.
Presence of even minor amounts (<1%) of fluorescent fatty acid or
lysolipid could lead to artifactual results due to their very rapid
spontaneous transfer (33) as compared with the intact phospholipid.
Such selective imaging of the intact phospholipid is obviously not
possible with the monopyrenyl or Bodipy derivatives.
Fig. 4 shows human fibroblast cells
incubated for 15 min at 37 °C with donor vesicles containing
DiPyr10PC in the presence or absence of 30 mM
CE-
We then carried out analogous labeling experiments with other
DiPyrnPC species in order to establish the limits of the
method, as well as to confirm that the enhanced labeling in the
presence of cyclodextrin is due to monomeric transfer of the fluorescent lipid rather than due to fusion or adherence/endocytosis of
the donor vesicles. The results are summarized in Fig.
5. As expected, most efficient
CE-
Although the dipyrenyl lipids used here were of high purity, the
fraction of the long-chain dipyrenyl lipids, such as
DiPyr10PC, transferred from the donor vesicles to cells is
rather small (see below). Therefore, it was considered necessary to
exclude the possibility that some, or even all, of the cell-associated
excimer fluorescence would derive from pyrene fatty acid/lysolipid
impurities rather than from intact DiPyr10PC. To accomplish
this, human fibroblast cells were incubated with donor vesicles
containing up to 1 nmol of Pyr10-fatty acid (which
corresponds to 5% fatty acid impurity in DiPyr10PC,
i.e. far more than could be present; see under
"Experimental Procedures") in the presence of 15 mM
CE-
To confirm that CE- Spontaneous Transfer of Long Chain Pyrenyl Lipids Is Similar to
That of Typical Natural Species--
To compare the spontaneous
transfer rate of the fluorescent analogues with that of natural
phospholipid species, we used a simple reverse-phase HPLC assay.
Previous studies have shown that there is a close correlation between
the rate of spontaneous transfer of a lipid and its retention time on a
reverse-phase column (34). Although such a correlation is strictly
valid only for members of a homologue series, reasonable estimates
should be obtained using this method. Accordingly, we determined the
retention times for different fluorescent PCs as well as for some
common natural species and calculated the relative rates of spontaneous
transfer. The results are shown in Table
I. Notably, the predicted rates for
Pyr10PC and DiPyr10PC are similar to that of
16:0/18:1 and significantly slower than that of two other common
natural species, 16:0/20:4-PC and 18:0/20:4-PC. The rate predicted for
DiPyr8PC is higher than that for 18:2/18:2-PC but lower
than that for 18:3/18:3-PC. In contrast, DiPyr4PC,
DiPyr6PC, Bodipy12-PC, and NBD12-PC
are predicted to transfer far more rapidly than any of these natural species.
To estimate the validity of these predictions, we determined the rate
of Pyr10PC directly using the assay shown in Fig. 1. The
half-time of transfer was found to be 74 h at 25 °C as
determined from a progress curve recorded over 48 h. This agrees
well with the value of 36 h obtained previously for
Pyr10PC at 37 °C (35). In comparison, a half time of
48 h has been obtained for 16:0/18:1-PC at 37 °C (36). Thus,
the rate of spontaneous transfer of Pyr10PC (and probably
that of DiPyr10PC as well) is indeed similar to that of
16:0/18:1-PC, as was predicted based on the retention time data (Table
I).
Incubation with CE-
To investigate the effect of the labeling procedure on long-term cell
viability, sparse (approximately 15% confluent) BHK cell monolayers
were subjected to labeling for 30 min at 25 °C and then incubated
for several days in the normal growth medium. In cyclodextrin-treated
cultures, the amount of cell protein increased from the prelabeling
value of 0.4 ± 0.1 mg to 3.5 ± 0.3 mg and in control
cultures to 3.4 ± 0.4 mg (n = 6). Hence, the
labeling procedure does not seem to affect the long term viability of
the cells either.
CE-
Previous studies have shown that
Certain cyclodextrins extract cholesterol efficiently from cells (14,
40), which may compromise cell viability or alter cellular metabolism
(41, 42). To study whether such cholesterol depletion also occurs under
present conditions, we incubated BHK cells with DiPyr10PC
containing donor vesicles in the presence or absence of 30 mM CE- Fluorescent Lipids Are Deposited Initially to the Outer Leaflet of
the Plasma Membrane--
To confirm that the CE-
In contrast, when BHK cells were labeled with DiPyr8PS for
15 min at 37 °C and then chased for 5 h at 37 °C, prominent
labeling of mitochondria was observed (Fig. 7b). Labeling of
these organelles is in agreement with previous data obtained for
NBD6PS (44), NBD12PS (45), and
DiPyr4PS (25) and can be explained as follows. The PS
molecules are initially introduced to the outer leaflet of the plasma
membrane, but they move rapidly to the inner leaflet with the
assistance of the aminophospholipid translocase (46). From the inner
leaflet, the fluorescent PS molecules move further, possibly via
spontaneous diffusion (see below), to various organelles, including
mitochondria, where they can be decarboxylated to PE (45, 47). We
conclude that the intracellular distribution modes of
DiPyr8PC and -PS are compatible with the proposition that
CE- Hydrophobic Dipyrenyl PS Is Not Transported Efficiently from the
Plasma Membrane to Mitochondria--
Because DiPyr8PS and
other fluorescent derivatives used previously (see above) are much less
hydrophobic (cf. Table I) than typical native PS species
(mostly 16:0/18:1 in BHK cells) (18), it was of interest to determine
whether more hydrophobic dipyrenyl PS species, also, would be
transported from plasma membrane to mitochondria.
DiPyr10PS, the predicted spontaneous transfer rate of which
is more than 10 times slower than that of DiPyr8PS (Table I), was introduced to BHK cells, and the cells were chased in normal
medium for up to 23 h. The results are summarized in Fig. 8. After a 30-min chase, the plasma
membrane was the most prominently labeled structure, as expected (Fig.
8a), but some labeling of intracellular structures was also
obvious. After 3 h (Fig. 8b), the juxtanuclear region,
possibly the endosomal recycling compartment (cf. Ref. 43)
was prominently labeled, along with the plasma membrane. At 5 h
(Fig. 8c), probe distribution remained similar, except that
juxtanuclear labeling was somewhat diminished, and punctate
fluorescence, presumably representing secondary endosomes, was
observed. After 23 h of chase (Fig. 8d), the overall
fluorescence intensity was somewhat diminished, and in most cells, the
punctate structures were more prominent than before. Notably, in none
of these images is there any indication that DiPyr10PS
would be present in mitochondria. This is in striking contrast with
what was observed here for DiPyr8PS (Fig. 7b)
and previously for DiPyr4PS and NBD12PS (25,
45), thus strongly suggesting that native plasma membrane PS, probably
consisting mainly of hydrophobic species (see under "Discussion"),
moves only very slowly, if at all, to these organelles.
CE- Intracellular Distribution of Hydrophobic Pyrene PS Indicates Slow
Efflux of Native Plasma Membrane PS Species to Intracellular
Organelles--
PS makes up as much as one-third of the phospholipids
in the inner leaflet of the mammalian cell plasma membrane (39). A high
concentration of PS may be required to support various crucial processes, such as fusion of exosome with the plasma membrane or the
protein kinase C reaction. It is totally unclear how the cell can
maintain so high a concentration of PS in the inner leaflet of the
plasma membrane. One possibility is that the plasma membrane PS
consists predominantly of saturated, hydrophobic species, as indicated
by the study of Keenan and Morre (51). Enrichment of hydrophobic
species in the plasma membrane could result from selective depletion of
the hydrophilic species due their facile transport to mitochondria and
decarboxylation therein, after the synthesis in the endoplasmic
reticulum (18). In addition, hydrophobic PS species could have a higher
affinity for lipid "rafts" that are targeted to the plasma membrane
(52). Once they have reached the plasma membrane, they would be
prevented from "leaking" to other organelles due to their very slow
spontaneous diffusion (see below). On the other hand, the hydrophobic
plasma membrane PS molecules are likely to incorporate into endosytic
vesicles and subsequently in other endosomal compartments. Our present results strongly support this model by showing that the hydrophobic fluorescent derivative, DiPyr10PS, is present in the plasma
membrane and in various endocytic compartments but apparently not in
the Golgi apparatus or mitochondria (Fig. 8). However, further studies are needed to determine whether DiPyr10PS correctly reports
on intracellular trafficking of natural plasma membrane PS species.
Previously, NBD12PS has been shown to move quite rapidly
from the plasma membrane to the Golgi apparatus and mitochondria (45).
Because the authors considered this fluorescent species as being
"relatively nonexchangeable," and because inhibition of vesicular
transport had no effect on labeling of the Golgi apparatus and
mitochondria, they proposed that the transport of NBD12PS
from the plasma membrane to these organelles is probably mediated by a
lipid transfer protein. As shown by Table I, NBD12PS is far
less hydrophobic than typical native species and can probably therefore
move from the plasma membrane to mitochondria by spontaneous diffusion
via the cytoplasm. Therefore, it is not necessary to invoke an
involvement of a transfer protein.
These results discussed above underline the importance of
considering molecular hydrophobicity when studying intracellular trafficking of PS and other lipids having access to the cytoplasmic leaflet of organelle membranes. Hydrophobicity is likely to be a
relevant parameter also in other contexts, as indicated by differential sorting of short and long chain fluorescent lipid derivatives within
the endosomal compartments (43).
-cyclodextrin (CE-
-CD) greatly
enhances transfer of a variety of hydrophobic fluorescent phospholipid
derivatives from vesicles to cultured cells. Several lines of evidence
indicate that CE-
-CD enhances transfer of lipid molecules by
increasing their effective concentration in the aqueous phase, rather
than by inducing membrane fusion or hemifusion. Incubation with
CE-
-CD and donor lipid vesicles does not extract cholesterol or
phospholipids from the cells or compromise plasma membrane intactness
or long term cell viability. Using CE-
-CD-mediated transfer, we
introduced hydrophobic pyrene-labeled phosphatidylserine to the plasma
membrane of fibroblast cells and followed their distribution with time.
In contrast to what has been previously observed for other, less
hydrophobic species, transport of this lipid to the Golgi apparatus or
mitochondria was not detected. Rather, much of this fluorescent PS
remained in the plasma membrane or was incorporated to various
endocytotic compartments. These findings indicate that the
native, typically hydrophobic phosphatidylserine molecules
efflux only very slowly via the cytoplasm to intracellular organelles.
This helps to explain how cells can maintain a very high concentration
of phosphatidylserine in the inner leaflet of their plasma membrane.
Furthermore, the present results underline the importance of using
hydrophobic analogues when studying intracellular trafficking of many
phospholipid classes.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-cyclodextrin derivatives were shown to mediate efficient
transfer of cholesterol between lipid vesicles and cells in culture
(14, 15). This led us to examine whether some cyclodextrins could be
used to introduce hydrophobic fluorescent phospholipid derivatives into
cultured cells. Primarily pyrene-labeled phospholipids were employed in
these studies because several systematically constructed sets were
available (16, 17), which helps to draw conclusions regarding the
mechanism of lipid transfer (18). The pyrenyl derivatives are also
attractive because they, in all respects studied so far, behave
similarly to natural lipids (16, 17, 19) and should allow one to map
microscopically lipid concentration gradients in cellular membranes
(20). Additional studies were carried out with Bodipy-labeled
derivatives, because they offer some advantages over the pyrene derivatives.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-CD stock solution was prepared in I-MEM and
adjusted to pH 7.4 to avoid acidification of the incubation medium.
This adjustment somewhat reduced the efficiency of labeling but was
necessary to avoid harmful effects to cells, particularly at higher
CE-
-CD concentrations. After the incubation, the cells were washed
three times with I-MEM and then subjected to imaging or lipid
extraction. For the latter, the cells were scraped into
phosphate-buffered saline, washed twice by centrifugation, and then
extracted according to Ref. 26. The amount of cell-associated
fluorescent lipid was determined by measuring the pyrene (excimer) or
Bodipy fluorescence intensity of the extract. Extracts of nonincubated
cells were used as blanks. Alternatively, the amount of cell-associated
fluorescent lipid was determined by HPLC analysis using on-line
fluorescence detection (27). For quantification, an internal standard
(a Bodipy or pyrene lipid, as appropriate) was added to the cell pellet
before the extraction. To determine vesicle binding to cells,
[3H]cholesterol oleate (50,000 cpm/dish) was included in
the donor vesicles.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-CD Greatly Enhances Transfer of Phospholipid Molecules
between Vesicles--
To test the ability of cyclodextrin derivatives
to enhance intermembrane phospholipid transport, we employed a
previously developed fluorescence assay (16). In this assay, the donor vesicles contain the pyrene lipid under study, TNP-PE, a quencher of
pyrene fluorescence, and unlabeled phospholipids, whereas the acceptor
vesicles consist of unlabeled lipids only. Transfer of the pyrene lipid
molecules from the donor to the acceptor vesicles results in
dequenching of pyrene fluorescence, which was recorded. Fig.
1 displays the result of an assay in
which transfer of 16:0/Pyr10PC was studied. When the donors
were incubated with the acceptor vesicles only, a very slow increase of
pyrene fluorescence was observed (Fig. 1, curve a),
indicating that the spontaneous transfer of this particular pyrene
lipid is a very slow process. Upon addition of 30 mM
CE-
-CD, a remarkable (~350-fold) increase in the rate of
fluorescence enhancement was observed (curve b), indicating that CE-
-CD greatly accelerates intervesicle translocation of Pyr10PC. As shown in the inset of Fig. 1, the rate of
transport is closely proportional to CE-
-CD concentration. Parallel
experiments were carried out with a variety of other cyclodextrin
derivatives, but none of them proved to be as efficient as CE-
-CD
(data not shown). Because CE-
-CD also remarkably enhanced
intervesicle transfer of other pyrenyl phospholipids as well as those
labeled with the NBD12 or Bodipy12 fatty acids
(not shown, but see below), CE-
-CD was chosen for further
experiments.

View larger version (13K):
[in a new window]
Fig. 1.
CE-
-CD greatly
enhances transfer of Pyr10PC from donor to acceptor
vesicles. Donor vesicles consisting of
Pyr10PC/POPC/POPA/TNP-PE (0.2:45:5:5 nmol) were incubated
with POPC/POPA (500:20 nmol) acceptor vesicles in the absence
(curve a) of presence (curve b) of 30 mM CE-
-CD. CE was added after 1.5 min of incubation.
Inset, effect of CE-
-CD concentration on the initial rate
of transfer.
-CD-mediated Transfer Is Strongly Dependent on Pyrene Lipid
Hydrophobicity--
To obtain information on the mechanism of
cyclodextrin-mediated phospholipid transfer, the effect of the length
of the pyrene-labeled acyl chain (6-14 carbons) on the rate of
CE-
-CD mediated transfer was investigated. As displayed in Fig.
2, the rate decreases strongly (exponentially) with increasing length of the pyrene-labeled chain. Analogous results were obtained for lipids that contained two pyrene-labeled chains of identical length (n = 6-14;
data not shown, but see below). Such strong chain length dependence of the rate of fluorescence increase (probe dilution) clearly indicates that CE-
-CD enhances monomeric transport of the labeled lipid molecules, rather than causes fusion or hemifusion between the donor
and acceptor vesicles. If either of the latter mechanisms were to
dominate, the rate of fluorescence increase would be independent of the
chain length of the pyrene phospholipid, which clearly is not the case.
In addition, the fact that hardly any increase of fluorescence was
observed for the pyrene PC with longest chain (see Fig. 2) excludes the
possibility that transfer of the quencher molecules, if occurring,
would significantly contribute to the observed enhancement of pyrene
fluorescence in this assay.

View larger version (8K):
[in a new window]
Fig. 2.
CE-
-CD-mediated
transfer PyrnPC species decreases systematically with
increasing acyl chain length (hydrophobicity). The transfer
assay was carried out as detailed in the legend to Fig. 1. The length
of the pyrene-labeled acyl chain was varied from 6 to 14 carbons. The
concentration of CE-
-CD was 5 mM. The data are averages
of three independent experiments. The spontaneous rate, which was
maximally 1.3% of the CE-
-CD-mediated rate, has been
subtracted.
-CD mediated pyrene phospholipid
transfer, quenched donor vesicles containing Pyr10PC were
titrated with CE-
-CD, and the pyrene emission spectrum was recorded.
The spectral intensity increased strongly upon addition of CE-
-CD, and the increase was proportional to the amount of CE-
-CD added (data not shown). Parallel results were obtained for the other PyrnPCs and DiPyrnPCs tested. These results are
analogous to those obtained previously for phospholipid carrier proteins (16, 17) and therefore strongly suggest that CE-
-CD forms
of soluble complexes with pyrene phospholipids in the aqueous phase,
thereby enhancing their translocation between vesicles (see under
"Discussion").
-CD-mediated Transport--
We also studied the effect of the
head group on the rate of cyclodextrin-enhanced transfer of
pyrene-labeled phospholipids (Fig. 3).
Among glycerophospholipids, transfer of phosphatidylglycerol, PE, PS,
and PC is similarly enhanced, whereas that of phosphatidylinositol is
enhanced about twice as much by 5 mM CE-
-CD. This more
rapid transfer of phosphatidylinositol is probably due to the
considerable polarity of the head group. Supporting this, transfer of
diglyceride, which has a very small polar moiety, is much less
efficient than that of the phospholipids. Notably, Pyr10SM
is transported almost 3 times more rapidly than Pyr10PC.
The additional hydroxyl group and double bond in the sphingosine moiety
obviously makes SM somewhat less hydrophobic than PC with similar acyl
chains. We conclude that the overall molecular hydrophobicity, rather
than some structural details, determines the rate of CE-
-CD-mediated
transport of the pyrenyl lipids.

View larger version (18K):
[in a new window]
Fig. 3.
Effect of the lipid head group on the
transfer of monopyrenyl lipids by CE-
-CD.
The initial rate of transfer was determined as detailed in the legend
to Fig. 1. The donor vesicles consisted of a
Pyr10-lipid/TNP-PE/POPC (0.2:5:45 nmol)
-CD Also Greatly Enhances Transfer of Hydrophobic Fluorescent
Lipids from Vesicles to Cultured Cells--
Having shown that
CE-
-CD mediates efficient transport of fluorescent phospholipids
between phospholipid vesicles in vitro, we next studied
whether these compounds also catalyze transport of fluorescent
phospholipids from vesicles to cells in culture. To this end, vesicles
containing a pyrene- or Bodipy-labeled phospholipid were incubated with
cell monolayers at room temperature or 37 °C, and after washing, the
amount of cell-associated fluorescent lipid was determined using either
fluorescence imaging or spectroscopy.
-CD. Clearly visible excimer fluorescence, mainly on the plasma
membrane, was observed in the presence of CE-
-CD (Fig.
4a), whereas practically none was detectable in its absence
(Fig. 4b). Parallel results were obtained for
DiPyr10PS (Fig. 4, c and d). Very
similar labeling efficiencies were obtained when the incubation was
carried at 25 °C for 30 min, whereas less efficient or marginal
labeling was observed when the incubation was carried out for 30 min at
18 or 10 °C, respectively (data not shown). CE-
-CD also strongly
enhanced transfer of the Bodipy-derivatives from the donor vesicles to
cells, as shown for Bodipy-SM in Fig. 4, e and f.
However, significant labeling of cells by Bodipy-SM (and other Bodipy
derivatives) occurred even in the absence of cyclodextrin, apparently
because of the relatively low hydrophobicity of the Bodipy derivatives
(see below). This is not clearly shown by Fig. 4f because of
the lower concentration of Bodipy12-SM donor vesicles used
(see legend to Fig. 4).

View larger version (85K):
[in a new window]
Fig. 4.
CE-
-CE greatly
enhances transfer of fluorescent phospholipids from donor vesicles to
cells. Monolayers of human fibroblasts on coverslips were
incubated with donor vesicles consisting of
DiPyr10PC/POPC/POPA/TNP-PE (20:170:10:20 nmol)
(a and b), DiPyr10PS/POPC//TNP-PE
(20:170:20 nmol; c, d) or Bodipy-SM/POPC/POPA (1:4.75:0.25
nmol) (e and f) in I-MEM for 30 min at 25 °C,
washed, covered with fresh I-MEM containing oxygen depletion reagents,
and imaged as detailed under "Experimental Procedures." In
a and c, 30 mM CE-
-CD and in
e 5 mM CE-
-CD was present during incubation,
whereas CE-
-CD was omitted in b, d, and f. The
camera settings and image adjustments were identical in each case. The
insets display the original images with the pixel
intensities multiplied by a factor of 20. Many of the brightest
structures visible in the insets are cell debris (see legend to Fig.
5). Note that much less Bodipy12-SM than DiPyrnPCs
was used.
-CD-mediated labeling was obtained with DiPyr6PC
(Fig. 5a). The efficiency decreased systematically with
increasing length of the acyl chains, and with DiPyr14PC, virtually no labeling was observed (Fig. 5i). For
DiPyr6PC and DiPyr8PC, significant labeling was
also observed in the absence of CE-
-CD (Fig. 5, b and
d), but not for the long chain derivatives (Fig. 5, f,
h, and j). Notably, the fact that practically no
labeling with the most hydrophobic pyrene lipids was observed in the
presence of CE-
-CD provides strong evidence that CE-
-CD enhances
monomeric transfer of the pyrene derivatives, rather than inducing
vesicle-cell fusion, adherence, or endocytotic uptake of vesicles.
These data also show that DiPyr10PC is the most hydrophobic
dipyrenyl derivative for which adequate levels of labeling were
achieved under the present labeling conditions.

View larger version (53K):
[in a new window]
Fig. 5.
CE-
-CD-mediated cell
labeling diminishes systematically with increasing hydrophobicity of
DiPyrnPC. Fibroblast monolayers on coverslips
were incubated with donor vesicles consisting of
DiPyrnPC/POPC/POPA/TNP-PE (20:170:10:20 nmol) in I-MEM at
37 °C for 15 min, washed, and imaged. DiPyrnPCs used were as
follows: DiPyr6PC (a and b),
DiPyr8PC (c and d),
DiPyr10PC (e and f),
DiPyr12PC (g and h), and
DiPyr14PC (i and j). In a, c,
e, g, and i, CE-
-CD (15 mM) was present,
whereas it was omitted in b, d, f, h, and j. The
camera settings and image adjustments were identical in each case. The
brightly fluorescent structures often seen to attach to cells or
matrix, in both the presence and the absence of cyclodextrin
(white arrows in a and e), consist of
cell debris. Presumably, debris may become strongly labeled either
because the PyrnPC monomers more readily integrate to the less
tightly packed (due to degradation) membranes and/or because donor
vesicles readily fuse with the membrane remnants of the debris.
-CD. No pyrene excimer fluorescence could be detected in the
cells (data not shown), thus demonstrating that the pyrene fluorescence
observed in cells incubated with DiPyr10PC and CE-
-CD
derives from intact lipids rather than from possible impurities.
-CD indeed mediates monomeric transfer of the
fluorescent lipids rather than causing fusion or association of the
donor vesicles with the cells, BHK cell monolayers were incubated with
donor vesicles containing a fluorescent lipid and [3H]cholesterol oleate, a nontransferable liposomal
marker, in the presence of 0-30 mM CE-
-CD for 30 min at
room temperature. Fig. 6a
shows results for Bodipy-SM. The amount of cell-associated Bodipy-SM
increased strongly with the CE-
-CD concentration up to 15 mM CE-
-CD. At this concentration, about 5% of the
liposomal Bodipy-SM has become cell-associated. In contrast, only about 0.3% of the [3H]cholesterol ester, the liposomal marker,
was associated with the cells independent of the CE-
-CD
concentration used. Parallel results were obtained for
DiPyr6PC except that somewhat less fluorescent PC was
transferred to the cells (Fig. 6b). These data are
consistent with the proposition that CE-
-CD enhances monomeric
transport of the fluorescent phospholipids from donor vesicles to
cells. We also carried out analogous experiments with
DiPyr10PC but could not obtain conclusive data, probably
because the fraction of this (much more hydrophobic) lipid (see below)
transferred to cells is quite small and comparable to the fraction of
vesicles adhering to cells or cell-associated debris. Nevertheless, the
imaging data in Fig. 5 clearly indicate that CE-
-CD indeed mediates
monomeric transfer of DiPyr10PC as well.

View larger version (11K):
[in a new window]
Fig. 6.
CE-
-CD enhances
monomeric transfer of fluorescent phospholipids to cells rather than
vesicle fusion or adhesion. (a) BHK cell monolayers
were incubated in I-MEM containing donor vesicles consisting of
Bodipy-SM, POPC, TNP-PE and POPA (5:42.5:5:2.5 nmol) and
[3H]cholesterol oleate (50,000 cpm) in the presence of
indicated amounts of CE-
-CD for 15 min at 37 °C. After washing,
the cells were scraped off, extracted and the amount of Bodipy-SM
(open symbols) and 3H radioactivity
(closed symbols) were determined by fluorescence
spectroscopy and liquid-scintillation counting, respectively.
b, as in a, but the donor vesicles contained
DiPyr6PC instead of Bodipy-SM. The data are means of two
parallel dishes, and the error bars indicate the difference
from the mean. Analogous results were obtained in similar experiments
in which the amount of the fluorescent lipid was determined by an HPLC
assay (see "Experimental Procedures").
Predicted spontaneous transfer rates of fluorescent and natural
phospholipid species
-CD Does Not Compromise Plasma Membrane
Intactness or Cell Viability--
To study whether the labeling
protocol perturbs the integrity of the plasma membrane, BHK cell
monolayers were incubated with donor vesicles containing
DiPyr10PC and 30 mM CE-
-CD either for 30 min
at 25 °C or for 15 min at 37 °C, and the activity of the cytosolic enzyme lactate dehydrogenase in the medium was determined. Under these conditions, 0.4 ± 0.15 or 1.3 ± 0.35%
(n = 4) of the total cellular lactate dehydrogenase was
found in the medium, respectively. For the control cells, incubated
similarly but in the absence of CE-
-CD, the values were 0.5 ± 0.19 and 1.3 ± 0.24% (n = 4), respectively. Thus
incubation with the cyclodextrin does not seem to compromise the
integrity of the cell membrane significantly. Supporting this
conclusion, visual inspections of treated and control cells revealed no
obvious differences in trypan blue penetration.
-CD Does Not Seem to Extract Phospholipids or Cholesterol
from the Cells--
To study whether incubation of with CE-
-CD and
donor vesicles alters the phospholipid composition of the cells, mass
spectroscopic measurements (37, 38) of the medium and the cells were
carried out. Because it is likely that phospholipids in the outer
leaflet of the plasma membrane would be preferentially extracted, the analyses were focused on PC, SM, and PE, which together represent nearly 100% of the outer leaflet phospholipids in BHK cells (39). Unfortunately, the phospholipid composition of the labeling medium could not be determined because of some compounds present interfered with the mass spectroscopic analysis. Analysis of the cells did not
reveal significant differences between those labeled and controls, except that the former contained somewhat more 16:0/18:1-PC. However, the increase of 16:0/18:1-PC was quite variable, and further
experiments (data not shown) indicated that this extra 16:0/18:1-PC is
not truly incorporated to cell membranes, but probably derives from donor vesicles adhering to the cells or cell debris. Notably, the
analysis of the total cellular lipid composition do not exclude the
possibility that some changes in the lipid composition of the plasma
membrane outer monolayer in fact occurs, because this compartment
contains only a fairly small fraction (13%) (39) of the total cellular phospholipid.
-cyclodextrin does not extract
phospholipids efficiently from erythrocytes, whereas the
-derivative
does (40). The larger hydrophobic cavity of
-cyclodextrins apparently favors complex formation with fluorescent lipids having bulky groups in the acyl chain(s) but disfavors complexation of phospholipids with natural acyl chains.
-CD for 30 min at 25 °C and then determined the
cholesterol content of the cells. The cells incubated with CE-
-CD
contained 22 ± 3.4 nmol of cholesterol/dish (n = 3), whereas the controls contained 24 ± 5. nmol/dish
(n = 4). Hence, the labeling procedure does not cause
significant depletion of cellular cholesterol. This, together with the
lack of significant extraction of phospholipids, probably explains why
the intactness of the cell membrane is maintained under the labeling
condition employed.
-CD-mediated cell
labeling is indeed due to (initial) incorporation of the fluorescent
lipid monomers to the outer leaflet of the cells, we labeled BHK cells
with DiPyr8PC and -PS as above and then followed the
distribution of these lipids during a chase at 37 °C using
fluorescence imaging. DiPyr8-derivatives were used here
because they can distribute more readily among accessible membranes
than the much more hydrophobic DiPyr10-derivatives (see
below). Fig. 7a shows BHK
cells labeled with DiPyr8PC and then chased for 5 h at
37 °C. As compared with situation before the chase (Fig.
5c), the plasma membrane fluorescence was strongly diminished, whereas there was a marked increase in the labeling of
intracellular structures, including punctate pericellular and more
diffuse perinuclear structures, which may represent secondary endosomes
and the endosytic recycling compartment, respectively (43). On the
other hand, no obvious labeling of the mitochondria or the nuclear
membrane was apparent. Parallel results were obtained with
DiPyr6PC (see below) and with DiPyr4PC
previously (25). These findings indicate that dipyrenyl PCs are
initially introduced as monomers to the outer leaflet of the plasma
membrane and later incorporate to endosomes and related organelles. If
fusion of the vesicles with cell membrane had occurred, labeling of the mitochondria and the nuclear membrane would be expected (see below and
cf. Ref. 4).

View larger version (96K):
[in a new window]
Fig. 7.
Distinct modes of labeling are observed for
DiPyr8PC and -PS after chasing at 37 °C. BHK cells
on coverslips were incubated with donor vesicles containing
DiPyr8PC (a) or DiPyr8PS
(b) for 15 min at 37 °C, washed, and then chased for
5 h in the growth medium before imaging. In the cells labeled with
DiPyr8PC, vesicular structures, probably endosomes, are
typically most strongly labeled, whereas DiPyr8PS labels
mitochondria (arrows) prominently.
-CD mediates monomeric incorporation of the fluorescent lipids
initially to the outer leaflet of the plasma membrane, rather than
inducing fusion or endocytosis of the donor vesicles.

View larger version (41K):
[in a new window]
Fig. 8.
DiPyr10PS is not transported
effectively to mitochondria. BHK cells growing on coverslips were
incubated with donor vesicles containing DiPyr10PS for 30 min at 37 °C, washed, and then further incubated for 0.5 (a), 3 (b), 5 (c), or 23 (d) h in the growth medium before imaging. It appears as if
the total fluorescence intensity of cells increases from 30 min to
3 h of chase. This increase is probably an imaging artifact
resulting from accumulation of fluorescent lipids to the central,
thicker regions of the cells. Due to significant contribution by out of
focus levels, the observed intensity appears to be higher than when the
fluorescent molecules are more evenly distributed within the
cell.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-CD Mediates Efficient Intermembrane Transfer of Hydrophobic
Fluorescent Phospholipids--
The present study demonstrates that
CE-
-CD greatly accelerates translocation of hydrophobic
pyrene-labeled phospholipids between vesicles, as well as from vesicles
to cells (Fig. 4). Also, the transfer of Bodipy12- and
NBD12-phospholipids was remarkably enhanced by CE-
-CD,
thus demonstrating that we are not dealing with a phenomenon unique for
the pyrene derivatives. Several lines of evidence (see under
"Results") indicate that CE-
-CD enhances monomeric transfer of
phospholipid molecules, rather than inducing membrane fusion or
hemifusion. It is not clear from the present experiments what the
precise mechanism of this monomeric transfer is. One obvious
possibility is that CE-
-CD forms soluble complexes with the lipid
molecule once it has fully or partially effluxed from the donor
membrane surface and then carries the complexed lipid to the acceptor
membrane. Several CE-
-CD molecules in turn could act as carriers (a
"relay" mechanism). The alternative, perhaps less probable
mechanism is that CE-
-CD increases the concentration of free
phospholipid monomers in the aqueous phase by forming
transient complexes close to the donor surface. Previous studies have established that the rate of (spontaneous) transfer of
phospholipids between membranes is proportional to the free monomer
concentration (48-50).
| |
ACKNOWLEDGEMENTS |
|---|
We are grateful to Krista Anttonen, Mirkka Koivusalo, and Perttu Haimi for assistance with various assays; Liisa Heikinheimo for critically reading the manuscript; and Tarja Grundström for skillful technical assistance.
| |
FOOTNOTES |
|---|
* This study was supported by grants from the Finnish Academy, the University of Helsinki, the FAIR Program of the European Union, and the Sigrid Juselius Foundation.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.: 358-9-191-8216;
Fax: 358-9-191-8276; E-mail: pentti.somerharju@helsinki.fi.
2 Tanhuanpää, Virtanen, J. A., and Somerharju, P., manuscript in preparation.
| |
ABBREVIATIONS |
|---|
The abbreviations used are:
PC, phosphatidylcholine;
PE, phosphatidylethanolamine;
PS, phosphatidylserine;
SM, sphingomyelin;
Bodipy, 4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-S-indacene;
Bodipy12, Bodipy-3-dodecanoylate;
Bodipy12-PC, 1-hexadecanoyl,2-(4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-indacene-3-dodecanoyl)-sn-glycero-3-PC;
Bodipy12-PE, 1-hexadecanoyl,2-(4,4-difluoro-5,7-dimethyl-4-bora-3a,
4a-diaza-s-indacene-3-dodecanoyl)-sn-glycero-3-PE;
Bodipy12-SM, n-(4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-indacene-3-dodecanoyl)-SM;
BP, band pass;
CE-
-CD, carboxyethyl-
-cyclodextrin;
NBD6PC, 2-(6-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)hexanoyl-1-hexadecanoyl-sn-glycero-3-PC;
NBD12PS, 2-(12-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)dodecanoyl-1-hexadecanoyl-sn-glycero-3-PS;
POPA, palmitoyl-oleoyl-phosphatidic acid;
POPC, palmitoyl-oleoyl-phosphatidylcholine;
PyrnPC, 16:0-pyrenylacyl-PC (n = carbons in the acyl chain);
DiPyrnPC, dipyrenylacyl-PC;
TNP-PE, N-trinitrophenyl-PE;
I-MEM, CO2-independent
medium, Life Technologies catalog number 18045;
HPLC, high pressure
liquid chromatography.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Dennis, E. A., and Kennedy, E. P. (1972) J. Lipid. Res. 13, 263-267[Abstract] |
| 2. |
Voelker, D. R.
(1991)
Microbiol. Rew.
55,
543-560 |
| 3. | van Meer, G., and van Genderen, I. L. (1994) Subcell. Biochem. 23, 1-24[Medline] [Order article via Infotrieve] |
| 4. |
Pagano, R. E.,
and Sleight, R. G.
(1985)
Science
229,
1051-1057 |
| 5. | Rosenwald, A. G., and Pagano, R. E. (1993) Adv. Lipid Res. 26, 101-118[Medline] [Order article via Infotrieve] |
| 6. | Koval, M., and Pagano, R. E. (1991) Biochim. Biophys. Acta 1082, 113-125[Medline] [Order article via Infotrieve] |
| 7. | Hoekstra, D., and Kok, J. W. (1992) Biochim. Biophys. Acta 1113, 277-294[Medline] [Order article via Infotrieve] |
| 8. |
Pagano, R. E.,
Longmuir, K. J.,
and Martin, O. C.
(1983)
J. Biol. Chem.
258,
2034-2040 |
| 9. |
Sleight, R. G.,
and Pagano, R. E.
(1985)
J. Biol. Chem.
260,
1146-1154 |
| 10. |
Sleight, R. G.,
and Pagano, R. E.
(1984)
J. Cell Biol.
99,
742-751 |
| 11. | Chattopadhyay, A., and London, E. (1987) Biochemistry 26, 39-45[CrossRef][Medline] [Order article via Infotrieve] |
| 12. | Wolf, D. E., Winiski, A. P., Ting, A. E., Bocian, K. M., and Pagano, R. E. (1992) Biochemistry 31, 2865-2873[CrossRef][Medline] [Order article via Infotrieve] |
| 13. |
van Meer, G.,
and Simons, K.
(1983)
J. Cell Biol.
97,
1365-1374 |
| 14. |
Kilsdonk, E. P.,
Yancey, P. G.,
Stoudt, G. W.,
Bangerter, F. W.,
Johnson, W. J.,
Phillips, M. C.,
and Rothblat, G. H.
(1995)
J. Biol. Chem.
270,
17250-17256 |
| 15. | Klein, U., Gimpl, G., and Fahrenholz, F. (1995) Biochemistry 34, 13784-13793[CrossRef][Medline] [Order article via Infotrieve] |
| 16. | Somerharju, P. J., van Loon, D., and Wirtz, K. W. (1987) Biochemistry 26, 7193-7199[CrossRef][Medline] [Order article via Infotrieve] |
| 17. | van Paridon, P. A., Gadella, T. W., Jr., Somerharju, P. J., and Wirtz, K. W. (1988) Biochemistry 27, 6208-6214[CrossRef][Medline] [Order article via Infotrieve] |
| 18. |
Heikinheimo, L.,
and Somerharju, P.
(1998)
J. Biol. Chem.
273,
3327-3335 |
| 19. | van Amerongen, A., Demel, R. A., Westerman, J., and Wirtz, K. W. (1989) Biochim. Biophys. Acta 1004, 36-43[Medline] [Order article via Infotrieve] |
| 20. | Dix, J. A., and Verkman, A. S. (1990) Biochemistry 29, 1949-1953[CrossRef][Medline] [Order article via Infotrieve] |
| 21. | Somerharju, P., and Wirtz, K. (1982) Chem. Phys. Lipids 30, 81-91 |
| 22. | Somerharju, P. J., Virtanen, J. A., Eklund, K. K., Vainio, P., and Kinnunen, P. K. (1985) Biochemistry 24, 2773-2781[CrossRef][Medline] [Order article via Infotrieve] |
| 23. | Via, D. P., Massey, J. B., Vignale, S., Kundu, S. K., Marcus, D. M., Pownall, H. J., and Gotto, A. M., Jr. (1985) Biochim. Biophys. Acta 837, 27-34[Medline] [Order article via Infotrieve] |
| 24. | Lusa, S., and Somerharju, P. (1998) Biochim. Biophys. Acta 1389, 112-122[Medline] [Order article via Infotrieve] |
| 25. | Kasurinen, J., and Somerharju, P. (1995) Biochemistry 34, 2049-2057[CrossRef][Medline] [Order article via Infotrieve] |
| 26. | Bligh, E. G., and Dyer, W. j. (1959) Can. J. Biochem. Biophys. 37, 911-917 |
| 27. |
Kasurinen, J.,
and Somerharju, P.
(1992)
J. Biol. Chem.
267,
6563-6569 |
| 28. | Englander, S., Calhoun, D., and Englander, J. (1987) Anal. Biochem. 161, 300-306[CrossRef][Medline] [Order article via Infotrieve] |
| 29. | Absolom, D. R. (1986) Methods Enzymol. 132, 95-180[Medline] [Order article via Infotrieve] |
| 30. | Rouser, G., Fkeischer, S., and Yamamoto, A. (1970) Lipids 5, 494-496[Medline] [Order article via Infotrieve] |
| 31. | Storrie, B., and Madden, E. A. (1990) Methods Enzymol. 182, 203-225[Medline] [Order article via Infotrieve] |
| 32. | Eklund, K. K., Virtanen, J. A., Kinnunen, P. K., Kasurinen, J., and Somerharju, P. J. (1992) Biochemistry 31, 8560-8565[CrossRef][Medline] [Order article via Infotrieve] |
| 33. | Pownall, H. J., and Smith, L. C. (1989) Chem. Phys. Lipids. 50, 191-211[CrossRef][Medline] [Order article via Infotrieve] |
| 34. |
Massey, J. B.,
Gotto, A. M., Jr.,
and Pownall, H. J.
(1982)
J. Biol. Chem.
257,
5444-5448 |
| 35. | Jones, J. D., and Thompson, T. E. (1989) Biochemistry 28, 129-134[CrossRef][Medline] [Order article via Infotrieve] |
| 36. | McLean, L. R., and Phillips, M. C. (1981) Biochemistry 20, 2893-2900[CrossRef][Medline] [Order article via Infotrieve] |
| 37. |
Han, X.,
and Gross, R. W.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
10635-10639 |
| 38. |
Brugger, B.,
Erben, G.,
Sandhoff, R.,
Wieland, F. T.,
and Lehmann, W. D.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
2339-2344 |
| 39. | Allan, D. (1996) Mol. Membr. Biol. 13, 81-84[Medline] [Order article via Infotrieve] |
| 40. | Ohtani, Y., Irie, T., Uekama, K., Fukunaga, K., and Pitha, J. (1989) Eur. J. Biochem. 186, 17-22[Medline] [Order article via Infotrieve] |
| 41. |
Pike, L. J.,
and Miller, J. M.
(1998)
J. Biol. Chem.
273,
22298-22304 |
| 42. |
Furuchi, T.,
and Anderson, R. G.
(1998)
J. Biol. Chem.
273,
21099-21104 |
| 43. |
Mukherjee, S.,
Soe, T. T.,
and Maxfield, F. R.
(1999)
J. Cell Biol.
144,
1271-1284 |
| 44. |
Martin, O. C.,
and Pagano, R. E.
(1987)
J. Biol. Chem.
262,
5890-5898 |
| 45. |
Kobayashi, T.,
and Arakawa, Y.
(1991)
J. Cell Biol.
113,
235-244 |
| 46. | Devaux, P. F. (1992) Ann. Rev. Biophys. Biomol. Struct. 21, 417-439[CrossRef][Medline] [Order article via Infotrieve] |
| 47. | Jasinska, R., Zborowski, J., and Somerharju, P. (1993) Biochim. Biophys. Acta 1152, 161-170[Medline] [Order article via Infotrieve] |
| 48. | Nichols, J. W. (1985) Biochemistry 24, 6390-6398[CrossRef][Medline] [Order article via Infotrieve] |
| 49. | Massey, J., Gotto, A., and Pownall, H. (1982) Biochemistry 21, 3630-3636[CrossRef][Medline] [Order article via Infotrieve] |
| 50. | Silvius, J. R. (1991) Chem. Phys. Lipids. 57, 241-252[CrossRef][Medline] [Order article via Infotrieve] |
| 51. | Keenan, T. W., and Morre, D. J. (1970) Biochemistry 9, 19-25[CrossRef][Medline] [Order article via Infotrieve] |
| 52. | van Meer, G. (1998) Trends in Cell Biology 8, 29-33[CrossRef][Medline] [Order article via Infotrieve] |
| 53. | Massey, J. B., Hickson, D., She, H. S., Sparrow, J. T., Via, D. P., Gotto, A. M., Jr., and Pownall, H. J. (1984) Biochim. Biophys. Acta 794, 274-280[Medline] [Order article via Infotrieve] |
This article has been cited by other articles:
![]() |
V. Kainu, M. Hermansson, and P. Somerharju Electrospray Ionization Mass Spectrometry and Exogenous Heavy Isotope-labeled Lipid Species Provide Detailed Information on Aminophospholipid Acyl Chain Remodeling J. Biol. Chem., February 8, 2008; 283(6): 3676 - 3687. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Koivusalo, M. Jansen, P. Somerharju, and E. Ikonen Endocytic Trafficking of Sphingomyelin Depends on Its Acyl Chain Length Mol. Biol. Cell, December 1, 2007; 18(12): 5113 - 5123. [Abstract] [Full Text] [PDF] |
||||